GLP-1 drugs , or glucagon-like peptide-1 receptor agonists , represent a remarkable innovation in how we approach type 2 diabetes . These injectable therapies work by stimulating the body’s natural GLP-1 https://socialmediainuk.com/story27651862/glp-1-a-major-advance-in-glucose-treatment